James Sally L, van Langenberg Daniel R, Taylor Kirstin M, Gibson Peter R
Eastern Health Clinical School, Monash University Box Hill Hospital Box Hill Victoria Australia.
Department of Gastroenterology Alfred Hospital and Monash University Melbourne Victoria Australia.
JGH Open. 2018 Aug 5;2(5):217-222. doi: 10.1002/jgh3.12076. eCollection 2018 Oct.
The syndrome of constipation with other abdominal symptoms ("proximal constipation") in ulcerative colitis (UC) is commonly recognized by practitioners but is poorly described, with no recognized definition and little understanding with regard to prevalence and effect of therapies on disease outcomes. This study aimed to address these issues in a cross-sectional, consecutive series of patients with UC.
A working definition of proximal constipation was established. Consecutive patients were recruited, and their disease activity, recent medications, and investigations plus abdominal symptoms were assessed at a study visit. Relevant clinical data were also extracted from medical records.
Of 125 patients with UC, (mean age 47, range 14-84 years, 61 male), 58 (46%) fulfilled the definition of proximal constipation. The main symptoms were reduced stool frequency (69%), hard stools (43%), abdominal pain (40%), excessive flatus (29%), straining (24%), and sensation of incomplete emptying (14%). Proximal constipation was associated with female gender (OR 3.45 [1.45-8.24]), left-sided (OR 2.84 [1.14-7.11]) and concurrently active disease (OR 5.56 [1.96-16.67]), but not age, disease duration or therapy. A total of 88% had an increase in anti-inflammatory therapy, with the use of laxatives or fiber supplements in 63% compared with 1.4% of those without proximal constipation.
Proximal constipation is common, and its risk increases in active and distal disease, especially in women. Validation of its definition and evaluation of therapeutic strategies are needed. A new term "ulcerative colitis-associated constipation syndrome" is proposed to more accurately depict its nature.
溃疡性结肠炎(UC)患者出现便秘并伴有其他腹部症状(“近端便秘”)的综合征在临床医生中普遍得到认可,但相关描述较少,尚无公认的定义,对于其患病率以及治疗对疾病结局的影响了解甚少。本研究旨在通过对一系列连续性UC患者进行横断面研究来解决这些问题。
确立了近端便秘的实用定义。招募连续性患者,并在研究访视时评估其疾病活动度、近期用药情况、检查结果以及腹部症状。还从病历中提取了相关临床数据。
在125例UC患者中(平均年龄47岁,范围14 - 84岁,男性61例),58例(46%)符合近端便秘的定义。主要症状包括排便频率降低(69%)、大便干结(43%)、腹痛(40%)、排气过多(29%)、排便费力(24%)以及排便不尽感(14%)。近端便秘与女性性别(比值比3.45 [1.45 - 8.24])、左侧病变(比值比2.84 [1.14 - 7.11])以及同时存在的活动期疾病(比值比5.56 [1.96 - 16.67])相关,但与年龄、病程或治疗无关。共有88% 的患者增加了抗炎治疗,63% 的患者使用了泻药或纤维补充剂,而无近端便秘患者的这一比例为1.4%。
近端便秘很常见,并在疾病活动期和远端病变患者中风险增加,尤其是女性。需要对其定义进行验证并评估治疗策略。建议使用新术语“溃疡性结肠炎相关便秘综合征”来更准确地描述其本质。